Advertisement

International Urology and Nephrology

, Volume 51, Issue 2, pp 351–358 | Cite as

Protective effect of astaxanthin against contrast-induced acute kidney injury via SIRT1-p53 pathway in rats

  • Dongmei Gao
  • Hu Wang
  • Yang Xu
  • Di Zheng
  • Quan Zhang
  • Wenhua LiEmail author
Nephrology - Original Paper

Abstract

Purpose

The present study was designed to further investigate the protective effect of astaxanthin (AST) on contrast-induced acute kidney injury (CI-AKI) in rats and the relationship between SIRT1-p53 pathway and astaxanthin.

Methods

40 adult male Sprague Dawley (SD) rats were randomly divided into five groups (n = 8/group): control (CON), normal rats treated with AST (AST), CM-treated (CM), CM rats treated with isoform of nitric oxide synthase (iNOS) inhibitor (iNOS + CM), and CM rats treated with AST (AST + CM). Serum creatinine (Scr) and blood urea nitrogen (BUN) values were measured at 72 h following the procedure. Hematoxylin and eosin (H–E) staining was used to observe the pathologic changes of kidney. Tunel staining was used to test apoptosis of kidney tubules. Oxidative stress, SIRT1 activity, nitric oxide (NO), and 3-nitrotyrosine (3-NT) content were individually measured with the commercial available kits.

Results

Compared with the CON group, Scr and BUN levels significantly increased in the CM group (P < 0.05), and the values in two pre-treatment groups (iNOS + CM and AST + CM) had significantly decreased (P < 0.05). H–E and Tunel staining had shown that renal tubular injury was severe in CM group. The renal injury score and apoptosis index in the two pre-treatment groups also decreased (P < 0.05). The present study showed that in CM group the levels of oxidative stress indicators significantly increased, and the activities of antioxidant stress indicators significantly decreased. These indicators in two pre-treatment groups significantly improved (P < 0.05). In the CM group the expression levels of SITR1 significantly increased, and the ac-p53/p53 significantly increased (P < 0.05). Compared with the CM group, in AST + CM group the expression levels of SIRT1 increased, the expression levels of p53 and ac-p53/p53 decreased (P < 0.05).The levels of NO and 3-NT in CM group significantly increased (P < 0.05). Compared the CM group, the levels in the two pre-treatment groups significantly decreased (P < 0.05).

Conclusions

Astaxanthin has a protective effect on CI-AKI, the mechanism may be related to the SIRT1-p53 pathway. Astaxanthin can reduce the content of NO and 3-NT in renal tissue of CI-AKI, and alleviate the renal injury induced by contrast agents.

Keywords

Acute kidney injury Astaxanthin Oxidative stress Apoptosis SIRT1-p53 pathway 3-NT 

Notes

Acknowledgements

This study was supported by a grant from the Six Talent Peaks Project in Jiangsu Province (CN) (2014-YY-007).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interest.

Ethical approval

Experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals published in P.R. China and with the approval of Xuzhou Medical University Ethics Committee.

Supplementary material

11255_2018_2027_MOESM1_ESM.docx (245 kb)
Supplementary material 1 (DOCX 245 KB)

References

  1. 1.
    Dai B, Liu Y, Fu L, Li Y, Zhang J, Mei C (2012) Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis 60(3):360–370.  https://doi.org/10.1053/j.ajkd.2012.02.332 Google Scholar
  2. 2.
    Cho JY, Jeong MH, Hwan Park S, Kim IS, Park KH, Sim DS, Yoon NS, Yoon HJ, Park HW, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC (2010) Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure. J Cardiol 56(3):300–306.  https://doi.org/10.1016/j.jjcc.2010.07.002 Google Scholar
  3. 3.
    Rundback JH, Nahl D, Yoo V (2011) Contrast-induced nephropathy. J Vasc Surg 54(2):575–579.  https://doi.org/10.1016/j.jvs.2011.04.047 Google Scholar
  4. 4.
    Seeliger E, Sendeski M, Rihal CS, Persson PB (2012) Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J 33(16):2007–2015.  https://doi.org/10.1093/eurheartj/ehr494 Google Scholar
  5. 5.
    Khan SK, Malinski T, Mason RP, Kubant R, Jacob RF, Fujioka K, Denstaedt SJ, King TJ, Jackson HL, Hieber AD, Lockwood SF, Goodin TH, Pashkow FJ, Bodary PF (2010) Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. Thromb Res 126(4):299–305.  https://doi.org/10.1016/j.thromres.2010.07.003 Google Scholar
  6. 6.
    Okazaki Y, Okada S, Toyokuni S (2017) Astaxanthin ameliorates ferric nitrilotriacetate-induced renal oxidative injury in rats. J Clin Biochem Nutr 61(1):18–24.  https://doi.org/10.3164/jcbn.16-114 PubMedCentralGoogle Scholar
  7. 7.
    Huang J, Gan Q, Han L, Li J, Zhang H, Sun Y, Zhang Z, Tong T (2008) SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE 3(3):e1710.  https://doi.org/10.1371/journal.pone.0001710 PubMedCentralGoogle Scholar
  8. 8.
    Chan SH, Hung CH, Shih JY, Chu PM, Cheng YH, Lin HC, Tsai KL (2017) SIRT1 inhibition causes oxidative stress and inflammation in patients with coronary artery disease. Redox Biol 13:301–309.  https://doi.org/10.1016/j.redox.2017.05.027 PubMedCentralGoogle Scholar
  9. 9.
    Yokomaku Y, Sugimoto T, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Nitta N, Haneda M, Koya D, Uzu T, Kashiwagi A (2008) Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 19(2):321–328.  https://doi.org/10.1681/asn.2007040481 PubMedCentralGoogle Scholar
  10. 10.
    Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA (2009) Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 192(3):711–718.  https://doi.org/10.2214/ajr.08.1413 Google Scholar
  11. 11.
    Kongkham S, Sriwong S, Tasanarong A (2013) Protective effect of alpha tocopherol on contrast-induced nephropathy in rats. Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia 33(1):116–123.  https://doi.org/10.3265/Nefrologia.pre2012.Nov.11736 Google Scholar
  12. 12.
    Al-Otaibi KE, Al Elaiwi AM, Tariq M, Al-Asmari AK (2012) Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide. Oxid Med Cell Longev 2012:831748.  https://doi.org/10.1155/2012/831748 PubMedCentralGoogle Scholar
  13. 13.
    Buyuklu M, Kandemir FM, Ozkaraca M, Set T, Bakirci EM, Topal E (2014) Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis? Eur Rev Med Pharmacol Sci 18 (4):461–470Google Scholar
  14. 14.
    Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks MF, Spandidos DA, Tsitsimpikou C, Tsatsakis A (2017) Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther 180:99–112.  https://doi.org/10.1016/j.pharmthera.2017.06.009 Google Scholar
  15. 15.
    Chung S, Shin BS, Hedlund E, Pruszak J, Ferree A, Kang UJ, Isacson O, Kim KS (2006) Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem 97(5):1467–1480.  https://doi.org/10.1111/j.1471-4159.2006.03841.x PubMedCentralGoogle Scholar
  16. 16.
    Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW (2002) Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416(6880):542–545.  https://doi.org/10.1038/nature730 Google Scholar
  17. 17.
    Oppenheimer H, Gabay O, Meir H, Haze A, Kandel L, Liebergall M, Gagarina V, Lee EJ, Dvir-Ginzberg M (2012) 75-kd sirtuin 1 blocks tumor necrosis factor alpha-mediated apoptosis in human osteoarthritic chondrocytes. Arthritis Rheum 64(3):718–728.  https://doi.org/10.1002/art.33407 PubMedCentralGoogle Scholar
  18. 18.
    Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya D (2013) Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (London, England: 1979) 124(3):153–164.  https://doi.org/10.1042/cs20120190 Google Scholar
  19. 19.
    Botta G, De Santis LP, Saladino R (2012) Current advances in the synthesis and antitumoral activity of SIRT1-2 inhibitors by modulation of p53 and pro-apoptotic proteins. Curr Med Chem 19(34):5871–5884Google Scholar
  20. 20.
    Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Sueyasu K, Washida N, Tokuyama H, Tzukerman M, Skorecki K, Hayashi K, Itoh H (2010) Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem 285(17):13045–13056.  https://doi.org/10.1074/jbc.M109.067728 PubMedCentralGoogle Scholar
  21. 21.
    Hao CM, Haase VH (2010) Sirtuins and their relevance to the kidney. J Am Soc Nephrol 21(10):1620–1627.  https://doi.org/10.1681/asn.2010010046 PubMedCentralGoogle Scholar
  22. 22.
    Ambati RR, Phang SM, Ravi S, Aswathanarayana RG (2014) Astaxanthin: sources, extraction, stability, biological activities and its commercial applications—a review. Mar Drugs 12(1):128–152.  https://doi.org/10.3390/md12010128 PubMedCentralGoogle Scholar
  23. 23.
    Miki W (1991) Biological functions and activities of animal carotenoids. Pure Appl Chem.  https://doi.org/10.1351/pac199163010141 Google Scholar
  24. 24.
    Borowitzka MA (2013) High-value products from microalgae—their development and commercialisation. J Appl Phycol 25(3):743–756.  https://doi.org/10.1007/s10811-013-9983-9 Google Scholar
  25. 25.
    Koller M, Muhr A, Braunegg G (2014) Microalgae as versatile cellular factories for valued products. Algal Res 6(Part A):52–63.  https://doi.org/10.1016/j.algal.2014.09.002 Google Scholar
  26. 26.
    Pérez-López P, González-García S, Jeffryes C, Agathos SN, McHugh E, Walsh D, Murray P, Moane S, Feijoo G, Moreira MT (2014) Life cycle assessment of the production of the red antioxidant carotenoid astaxanthin by microalgae: from lab to pilot scale. J Clean Product 64(Supplement C):332–344.  https://doi.org/10.1016/j.jclepro.2013.07.011 Google Scholar
  27. 27.
    Qiu X, Fu K, Zhao X, Zhang Y, Yuan Y, Zhang S, Gu X, Guo H (2015) Protective effects of astaxanthin against ischemia/reperfusion induced renal injury in mice. J Transl Med 13:28.  https://doi.org/10.1186/s12967-015-0388-1 PubMedCentralGoogle Scholar
  28. 28.
    Li G-S, Chen X-L, Zhang Y, He Q, Wang F, Hong D-Q, Zhang P, Pu L, Zhang Y, Yang X-C, Wang L (2010) Malnutrition and inflammation in acute kidney injury due to earthquake-related crush syndrome. BMC Nephrol 11(1):4.  https://doi.org/10.1186/1471-2369-11-4 PubMedCentralGoogle Scholar
  29. 29.
    Qian J, You H, Zhu Q, Ma S, Zhou Y, Zheng Y, Liu J, Kuang D, Gu Y, Hao C, Ding F (2013) Nitrotyrosine level was associated with mortality in patients with acute kidney injury. PLoS ONE 8(11):e79962.  https://doi.org/10.1371/journal.pone.0079962 PubMedCentralGoogle Scholar
  30. 30.
    Tan X, Zheng X, Huang Z, Lin J, Xie C, Lin Y (2017) Involvement of S100A8/A9-TLR4-NLRP3 inflammasome pathway in contrast-induced acute kidney injury. Cell Physiol Biochem 43 (1):209–222.  https://doi.org/10.1159/000480340 Google Scholar
  31. 31.
    Kwasa EA, Vinayak S, Armstrong R (2014) The role of inflammation in contrast-induced nephropathy. Br J Radiol 87(1041):20130738.  https://doi.org/10.1259/bjr.20130738 PubMedCentralGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Dongmei Gao
    • 1
  • Hu Wang
    • 1
  • Yang Xu
    • 1
  • Di Zheng
    • 2
  • Quan Zhang
    • 2
  • Wenhua Li
    • 1
    • 2
    Email author
  1. 1.Institute of Cardiovascular Disease ResearchXuzhou Medical UniversityXuzhouChina
  2. 2.Department of CardiologyThe Affiliated Hospital of Xuzhou Medical UniversityXuzhouChina

Personalised recommendations